<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To characterise the main clinical phenotypes of <z:e sem="disease" ids="C0017922" disease_type="Disease or Syndrome" abbrv="">debrancher deficiency</z:e> <z:hpo ids='HP_0003198'>myopathy</z:hpo> and to increase awareness for this probably underdiagnosed disorder </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The diagnosis of <z:e sem="disease" ids="C0017922" disease_type="Disease or Syndrome" abbrv="">debrancher deficiency</z:e> was established by laboratory tests, EMG, and muscle and liver biopsy </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Four patients with <z:e sem="disease" ids="C0017922" disease_type="Disease or Syndrome" abbrv="">debrancher deficiency</z:e> <z:hpo ids='HP_0003198'>myopathy</z:hpo> were identified in the Tyrol, a federal state of Austria with half a million inhabitants </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical appearance was highly variable </plain></SENT>
<SENT sid="4" pm="."><plain>The following phenotypes were differentiated: (1) <z:hpo ids='HP_0003581'>adult onset</z:hpo> distal <z:hpo ids='HP_0003198'>myopathy</z:hpo>; (2) <z:hpo ids='HP_0011011'>subacute</z:hpo> <z:hpo ids='HP_0003198'>myopathy</z:hpo> of the respiratory muscles; (3) severe generalised <z:hpo ids='HP_0003198'>myopathy</z:hpo>; and (4) minimal variant <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003546'>Exercise intolerance</z:hpo> was uncommon </plain></SENT>
<SENT sid="6" pm="."><plain>The clinical course was complicated by advanced <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> in two patients and by severe <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in one </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had raised <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase concentrations (263 to 810 U/l), myogenic and neurogenic features on EMG, and markedly decreased debrancher enzyme activities in muscle or liver biopsy specimens </plain></SENT>
<SENT sid="8" pm="."><plain>The findings were substantiated by a review of 79 previously published cases with neuromuscular <z:e sem="disease" ids="C0017922" disease_type="Disease or Syndrome" abbrv="">debrancher deficiency</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This study illustrates the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of neuromuscular manifestations in <z:e sem="disease" ids="C0017922" disease_type="Disease or Syndrome" abbrv="">debrancher deficiency</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Based on the clinical appearance, age at <z:hpo ids='HP_0003674'>onset</z:hpo>, and course of disease four phenotypes may be defined which differ in prognosis, frequency of complications, and response to therapy </plain></SENT>
</text></document>